NCT03352726View on ClinicalTrials.gov

A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

November 24, 2017

Primary Completion Date

June 29, 2018

Study Completion Date

June 29, 2018

Conditions

Peanut Allergy

Interventions

DRUG

DBV712 IHRP

DBV712 Solution for Skin Prick Test

Trial Locations (2)

72202

Arkansas Children's Hospital, Little Rock

80045

Children's Hospital Colorado, Aurora

Sponsors

Lead Sponsor

DBV Technologies

All Listed Sponsors

lead

DBV Technologies

INDUSTRY

NCT03352726 - A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects | Biotech Hunter | Biotech Hunter